On August 19, Intuitive Surgical rose 3.01% in regular trading, trading at $404.04/share, with turnover of $121 million.

On the news front, the company announced it has signed a lease agreement with Penang Development Corporation (PDC) to build a new 316,000-square-foot production facility in Penang, Malaysia. The facility is expected to begin production in 2028 and create 1,200 high-skilled jobs by 2032, manufacturing instruments and electromechanical equipment for the da Vinci surgical system to meet growing Asia-Pacific demand.

The expansion is supported by strong regional performance. The company's Q2 earnings showed European and Asia-Pacific da Vinci procedure volumes both grew 20% year-over-year, with markets including India, Italy, and the UK performing notably well. Additionally, Oppenheimer recently upgraded the stock to Outperform with a $500 price target, citing competitors' workflow challenges and real estate issues that limit their long-term appeal against Intuitive Surgical's dominant position.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)